---
title: "Shanghai Kai Kai Industrial Company Limited (600272.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600272.SH.md"
symbol: "600272.SH"
name: "Shanghai Kai Kai Industrial Company Limited"
industry: "Pharmaceuticals"
datetime: "2026-05-20T11:31:41.410Z"
locales:
  - [en](https://longbridge.com/en/quote/600272.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600272.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600272.SH.md)
---

# Shanghai Kai Kai Industrial Company Limited (600272.SH)

## Company Overview

Shanghai Kai Kai Industry Company Limited engages in the wholesale and retail of pharmaceutical products in China. The company is involved in the wholesale and retail of Chinese and Western medicines, prepared slices of Chinese medicinal herbs, medical devices, ginseng and tonic products, beauty and health products, and other health products and services under the Lei Yunshang brand. It also engages in the wholesale and retail of shirts, sweaters, jackets, coats, and other clothing items under the Kai Kai brand, as well as the purchase and customization of workwear. The company was founded in 1992 and is headquartered in Shanghai, China.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | CN Market |
| Website | [www.chinesekk.com](https://www.chinesekk.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: C (0.46)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 155 / 215 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.28% |  |
| Net Profit YoY | 16.68% |  |
| P/B Ratio | 4.09 |  |
| Dividend Ratio | 0.33% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3257414773.23 |  |
| Revenue | 1134301159.40 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 3.24% | C |
| Profit Margin | 2.03% | C |
| Gross Margin | 16.41% | D |
| Revenue YoY | 0.28% | C |
| Net Profit YoY | 16.68% | C |
| Total Assets YoY | 15.76% | B |
| Net Assets YoY | 27.35% | A |
| Cash Flow Margin | 266.65% | A |
| OCF YoY | 0.28% | C |
| Turnover | 0.68 | B |
| Gearing Ratio | 52.78% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Shanghai Kai Kai Industrial Company Limited",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "0.28%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "16.68%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "4.09",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.33%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "3257414773.23",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1134301159.40",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "3.24%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "2.03%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "16.41%",
          "rating": "D"
        },
        {
          "name": "Revenue YoY",
          "value": "0.28%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "16.68%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "15.76%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "27.35%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "266.65%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "0.28%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.68",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "52.78%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 141.33 | 152/215 | 275.87 | 230.87 | 173.52 |
| PB | 4.09 | 169/215 | 5.06 | 4.68 | 4.34 |
| PS (TTM) | 2.87 | 71/215 | 3.22 | 3.03 | 2.92 |
| Dividend Yield | 0.33% | 142/215 | 0.33% | 0.31% | 0.29% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Allist (688578.SH) | A | A | B | A | B | A |
| 02 | Xingqi Pharmaceutical (300573.SZ) | A | A | A | A | B | A |
| 03 | Hengrui Pharma (600276.SH) | A | B | C | A | B | B |
| 04 | Yunnan Baiyao (000538.SZ) | B | C | B | B | C | B |
| 05 | Haisco (002653.SZ) | A | A | B | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/600272.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/600272.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/600272.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/600272.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**